VOLUNTEER WITH US! Become part of Well Pharma Medical Research, Corp!

ABOUT WPMR

About Us

Well Pharma Medical Research was started in 2006 Eddie Armas MD as a Principal Investigator & Medical Director with a very professional and qualified staff.

About Early Phase

Face one unit with large capacity located near both South Miami and Larkin Hospitals.

About Late Phase

Late Phase is our second unit reliable and efficient with high-quality data.

Pharmacy

Security is the primary focus at our Pharmacy. Limited access is strictly enforced, and all study drug is kept in a secure, double-locked medication room.

Laboratory

With a CLIA Certified Clinical Lab On-Site, our laboratory is CLIA, IATA and OSHA Certification.

Data Management

System Proficiencies: Forward, Oracle, Medrio, Inform, Rave, Medidata.

Volunteer – Enrolling Studies

Vitiligo:

Vitiligo: VOLUNTEER – ENROLLING STUDIES
Vitiligo:

Participants aged 18 years or older (no upper age limit) at Screening. A clinical diagnosis of nonsegmental vitiligo for at least 3 months.

Gout

Gout

Adult men or women ≥ 18 years of age. Uncontrolled gout was defined as sUA ≥ 7 mg/dL at Visit 1.

Chronic Rhinosinusitis with Nasal Polyps

Chronic Rhinosinusitis with Nasal Polyps
Participants are aged 18 to 75 years of age, and physician-diagnosed with Chronic Rhinosinusitis with Nasal Polyps for at least 6 months before the Visit 1. Severity consistent with the need for surgery as defined by an endoscopic bilateral nasal polyp score of at least 5 out of 8 and a minimum score of 2 in each nasal cavity at the Visit 1. Had a documented exacerbation of nasal polyposis in the last 24 Months.

COPD (Chronic Obstructive Pulmonary Disease)

COPD (Chronic Obstructive Pulmonary Disease)

Male or female, age >40 years. COPD diagnosis for at least 12 months before the screening visit, and using a daily inhaled maintenance therapy for their COPD for at least 3 months.

Menstrual Migraine

Menstrual Migraine

Individuals, at least 18 years old with a regular menstrual cycle within the range of 21 to 35 days in length. Migraine onset before age 50 years.

Gout Flares

Gout Flares
Male and female subjects ≥ 18 years of age, with a clinical diagnosis of gout and a gout flare in the target joint that began within 96 hours before the Screening/Baseline Visit without the use of any product containing paracetamol/acetaminophen within 4 hours before the
Visit 1.

CLINICAL RESEARCH EXPERIENCE

We are among the leaders in methodological approaches to health care research and meta-analysis/systematic reviews.

WE HAVE WORKED WITH MANY PHARMACEUTICAL COMPANIES SUCH AS:

 
https://www.merck.com/index.html

IN ADDITION, WE HAVE ALSO WORKED WITH THE FOLLOWING CROs: